Even more pronounced expression changes were observed for LINC00152, also referred to as CYTOR, whose herein described upregulation in pancreatic cancer confirmed a recent finding using a small cohort of six PDAC and five control tissues [45]. The gene discussed is CYTOR; the disease is familial pancreatic carcinoma.